People who have received varicella vaccine when it was indicated and have no history of prior or subsequent varicella infection are not recommended to receive a zoster vaccine

People who have received varicella vaccine when it was indicated are not recommended to receive a zoster vaccine. Studies of the safety and immunogenicity of zoster vaccines in this setting are limited, and data are currently insufficient to suggest a benefit from vaccination. Preliminary information suggests that the incidence of herpes zoster in people who have received varicella vaccine is lower than in people infected with wild-type varicella.^31-33

People who are uncertain if they have received a previous varicella vaccine, or have a history of varicella infection before or after varicella vaccination can be considered for zoster vaccination.

Shingrix is funded through the NIP for non-Indigenous people aged ≥65 years, Aboriginal and Torres Strait Islander people aged ≥50 years and people aged ≥18 years with moderate or severe immunocompromising conditions that put them at the highest risk of herpes zoster.